ERBB2 and gastric cancer: HER2-positive GC is defined as HER2 immunohistochemistry (IHC) 3 + or 2 + /in situ hybridization (ISH) + (ERBB2/CEP17 ≥ 2.0) and accounts for approximately 15% of GCs.